PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Period	fcf
2021-12-31	-$57.93M
2022-12-31	-$83.03M
2023-12-31	-$133.21M
2024-12-31	-$103.62M

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PRCT	$25.12	+0.00%	0.80M
3
4
5

PROCEPT BioRobotics Corporation (PRCT) Free Cash Flow

Free Cash Flow Data

Get PROCEPT BioRobotics Corporation Data in Excel

More PRCT Financial Data